Last updated: August 3, 2025
Introduction
Patent KR20170103934, granted by the Korean Intellectual Property Office (KIPO), addresses innovations within the pharmacological or therapeutic domain, likely pertaining to a novel compound, formulation, or method of use. As South Korea’s patent system emphasizes both broad claims to secure competitive advantage and precise claims to ensure validity, deciphering the scope and analyzing the landscape around KR20170103934 is essential for stakeholders including pharmaceutical companies, R&D entities, and patent strategists.
This analysis dissects the patent’s claims, delineates their scope, compares them within relevant patent landscapes, and evaluates strategic implications.
Patent Overview and Technical Disclosure
While the exact patent document is not provided, typical structure suggests that KR20170103934 involves a chemical or biological innovation—possibly a therapeutic compound or a delivery method. Such patents often include:
- Chemical structure claims: covering a compound core and derivatives
- Method-of-use claims: encompassing therapeutic applications and treatment methods
- Formulation claims: specific dosage forms or combinations
- Process claims: methods of manufacturing or synthesis
Scope of Claims
1. Independent Claims
The primary independent claim in a pharmaceutical patent like KR20170103934 likely defines the invention’s core concept — such as a novel compound or therapeutic method. Typical features include:
- Structural scope: a chemical scaffold with defined substituents.
- Utility scope: specific indications or disease targets.
- Method scope: administration techniques or protocols.
The claims probably encompass a broad genus of compounds, often via Markush formulas, intended to maximize coverage while maintaining novelty and inventive step.
2. Dependent Claims
Dependent claims specify particular embodiments or narrower variants, including:
- Specific chemical substituents or configurations.
- Optimized dosing regimens.
- Specific pharmaceutical excipients or delivery systems.
- Use cases for particular diseases or conditions.
This layered claim structure ensures a robust patent position—broad coverage augmented by detailed embodiments.
Legal and Strategic Scope
- Protection Breadth: The scope hinges on the chemical novelty and inventive step. Broad claims dominate, limiting competitors from developing similar compounds or methods.
- Validity & Vulnerabilities: Overly broad claims risk invalidation if prior art demonstrates obviousness; claims targeted at narrow embodiments reduce this risk.
- Market Implication: Wide claims increase defensive leverage but may invite challenges; narrow claims might limit market exclusivity but enhance enforceability.
Patent Landscape Analysis
1. Prior Art Considerations
Patentability hinges on novelty over prior art including:
- Similar compounds: US and European patents on analogous chemical classes.
- Therapeutic methods: Existing patents on treatment protocols for similar indications.
- Publications: Scientific literature that discloses comparable structures or methods.
In East Asian jurisdictions like Korea, chemical patent claims are scrutinized heavily for inventive step, especially concerning known scaffolds with minor modifications.
2. Related Patents and Patent Families
A patent landscape reveals multiple related filings:
- Global family members: US, EP, JP, and CN filings sharing priority.
- Stage of prosecution: Whether claims are granted or pending elsewhere affects strategic leverage.
- Citations and Opposition: Internal and external citations highlight patent strength and potential vulnerabilities.
The presence of family patents suggests a broader R&D strategy, while overlapping claims may create licensing or litigation considerations.
3. Competitive & Patent Thickets
Key considerations in the landscape include:
- Existing patents on similar compounds: Potential overlap signals risk of litigation or invalidation.
- Patent fences: Crafting claims around known compounds to carve out a unique niche.
- Freedom-to-operate (FTO): Determining whether the patent obstructs commercial activities.
Effective landscape analysis indicates whether KR20170103934 fills a genuine innovation gap or overlaps with anticipated prior disclosures.
Implications for Stakeholders
- Pharmaceutical Developers: The scope defines potential freedom to operate and patent enforcement opportunities.
- Licensees & Partners: Broader claims might offer leverage for licensing negotiations or partnerships.
- Competitors: Needs to conduct thorough prior art searches and landscape mapping to design around or challenge claims.
Legal Status & Maintenance
The patent’s enforceability depends on maintenance payments and compliance with statutory deadlines. The patent life up to 20 years from filing suggests strategic considerations for commercialization timelines.
Conclusion
KR20170103934 exhibits a strategic claim architecture typical of innovative South Korean pharmaceutical patents—balancing broad protective scope with detailed embodiments. Its landscape is characterized by prior art overlaps and competitive patent portfolios, necessitating vigilant FTO analyses.
Key Takeaways
- The patent’s broad claims likely cover a genus of compounds or methods, crucial for market exclusivity but requiring defensibility against prior art.
- A comprehensive landscape review is vital—identifying overlapping patents ensures robust protection and minimizes litigation risks.
- Strategic claim drafting, focusing on narrow, inventive embodiments, enhances validity and enforceability.
- Monitoring renewal and opposition status abroad helps assess global patent strength and commercial potential.
- For innovators, integrating this patent within a broader IP portfolio enhances overall competitive positioning.
FAQs
1. How does the scope of KR20170103934 compare with similar patents filed internationally?
KR20170103934's claims are designed to mirror or extend claims made in corresponding patent applications worldwide (e.g., PCT or regional filings). Comparative analysis reveals whether it broadens, narrows, or aligns with international counterparts, impacting global IP strategy.
2. What are common vulnerabilities in pharmaceutical patents like KR20170103934?
Vulnerabilities typically include insufficient novelty over prior art, narrow inventive step, or claims that are too broad and thus susceptible to invalidation. Patent drafting should carefully balance scope with specificity.
3. How can competitors design around such patents?
Competitors can identify and modify structural features covered by dependent claims or develop alternative methods for achieving similar therapeutic effects without infringing core claims, provided such routes are supported by prior art and non-infringement analysis.
4. What is the significance of patent family data in landscape analysis?
Patent families provide insight into R&D priorities and strategic regional protections. A broad family indicates significant investment, affecting licensing and enforcement efforts.
5. How does the South Korean patent system influence the robustness of patents like KR20170103934?
South Korea employs a rigorous substantive examination process, demanding clear inventive step and novelty. This enhances patent quality but necessitates precise claim drafting and thorough prior art searches.
References
[1] Korean Intellectual Property Office (KIPO). Patent KR20170103934. Publicly available filings and legal status reports.
[2] WIPO Patent Landscape Reports. Analysis of pharmaceutical patent strategy in East Asia.
[3] European Patent Office (EPO). Guidelines for Examination of Chemical Inventions.
[4] World Patent Index. Prior art references related to pharmaceutical patents.
[5] PatentScope. Patent family data and international patent filings.
